(Date:12/16/2009)... 8 percent of children are uninsured, government report finds ... first six months of this year, 45.4 million Americans ... population -- had no health insurance, according to new ... addition, 58.4 million (19.4 percent) people of all ages ... year prior to the interview, and 31.9 million (10.6 ...
(Date:12/16/2009)... A new software program developed by CareRise ... facilities to calculate their staffing needs as it relates ... allows inpatient healthcare facilities to calculate their mandatory nurse-to-patient ... and receive a daily report as to how it ... leader in risk management in the healthcare industry, has ...
(Date:12/16/2009)... a 1st century shrouded man found in a tomb on ... the earliest proven case of leprosy. Details of the research ... Journal. , The molecular investigation was undertaken by Prof. ... F. Kuvin Center for the Study of Infectious and Tropical ... and Ms. Kim Vernon of Lakehead University, Canada, Prof. Azriel ...
(Date:12/16/2009)... Fortune 1000 employers strongly indicates that wellness programs have a ... , ... Minneapolis, MN (PRWEB) December 16, ... that 78 percent of employers have improved employee participation in ... In the survey, conducted by Hallmark Insights, a leader ...
(Date:12/16/2009)... Dec. 16 For ages, people from around ... therapeutic properties. Its soothing waters have a reputation that ... its involvement with miracles. Now, with the introduction of ... bathers can enjoy the legendary benefits of Dead Sea ... salt lines contain all-natural Dead Sea salt and essential ...
Breaking Medicine News(10 mins):Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3... Therapy Association (ASCTA) is formed in response to the Food and ... in everyone,s body are drugs, a position the ASCTA opposes. ... to bring adult stem cell therapy to their patients more quickly. ... ...
... NATICK, Mass., March 26 Boston Scientific Corporation (NYSE: ... the Company,s major events and news announcements at the ... Cardiology / i2 Summit, which runs from March 28-31 ... additional analyses of one-year data from the landmark SYNTAX ...
... GPO Customer HospitalsBETHEL, Conn., March 26 MedClean ... of innovative technology and services for onsite treatment ... announced that its RMW solutions, including its flagship ... by MedAssets Supply Chain Systems, a leading group ...
... March 26 It was on a train ride with a ... Cardille began her painful journey on the road to recovering from ... out of the blue if Lori thought his father was a ... face her past, and part of her healing process included writing ...
... Serve As Benchmark to Measure Upcoming Healthcare Reform ... expected during newly elected President Obama,s term, results ... Tri-State Area Employee Benefit Survey could prove to ... healthcare reform legislation can be measured.The survey was ...
... Cost-Effective OptionFORT COLLINS, Colo., March 26 Food ... builds immunity to food allergens from the comfort ... gently builds tolerance to targeted foods. The Allertherapy(TM) ... It quickly builds immunity to allergens and maintains ...
Other Medicine News:Health News:Physician Group Opposes FDA's Position on Adult Stem Cells 2Health News:Physician Group Opposes FDA's Position on Adult Stem Cells 3Health News:Boston Scientific Announces Schedule For ACC 2009 2Health News:Boston Scientific Announces Schedule For ACC 2009 3Health News:Boston Scientific Announces Schedule For ACC 2009 4Health News:Boston Scientific Announces Schedule For ACC 2009 5Health News:Boston Scientific Announces Schedule For ACC 2009 6Health News:MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract 2Health News:MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract 3Health News:'I'm Gonna Tell ... an offbeat tale of survival' 2Health News:Cowden Associates Releases Eighth-Annual Employee Benefit Survey Results 2Health News:Cowden Associates Releases Eighth-Annual Employee Benefit Survey Results 3Health News:New OTC Allergy Treatment Available to Food Allergy Sufferers 2(Date:12/16/2009)... Naurex Inc., a new clinical stage ... CNS disorders based on its novel GFPA NMDA ... a Phase I clinical trial of its lead ... subjects in the study. GLYX-13, a glycine ... the NMDA receptor, is initially being developed as ...
(Date:12/16/2009)... an inhalation drug delivery company, today announced that it ... financing round, exceeding the targeted total raise amount of ... Series A round will be utilized to continue the ... have the runway and resources to effectively demonstrate the ... Neville, CEO of Savara. ,, The company also ...
(Date:12/16/2009)... VIEW, Calif., Dec. 16 ChemoCentryx, Inc. ... in a Phase 2 clinical trial of CCX354, ... specifically target the CCR1 chemokine receptor for the ... is a highly potent and selective antagonist of ... of immune cells, such as monocytes and macrophages, ...
Breaking Medicine Technology:Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 61871 1Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 61871 2Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 61871 3Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 61871 4U S Bishops Voice Disappointment in Abortion Funding Provisions in Senate Health Bill Urge Better Care for Immigrants and Affordability 61867 1U S Bishops Voice Disappointment in Abortion Funding Provisions in Senate Health Bill Urge Better Care for Immigrants and Affordability 61867 2Amaizing 3A Corn genome decoded 14937 1Amaizing 3A Corn genome decoded 14937 2Amaizing 3A Corn genome decoded 14937 3Amaizing 3A Corn genome decoded 14937 4... Summary: Genmab,has completed recruitment of patients in the ... and cyclophosphamide to treat front line,CLL., Genmab ... recruitment of,56 patients in the Phase II study ... cyclophosphamide (FC) to treat chronic,lymphocytic leukemia (CLL) in ...
... July 9 Cerimon Pharmaceuticals,Inc., announced today ... study of,Simulect(R) (basiliximab) for the treatment of ... of the eye. The,randomized, double-masked, placebo-controlled study ... as maintenance therapy in 56 patients.,During the ...
Other Medicine Technology:Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study 2Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:Biology NavigationMedical Navigation